Years Active: 2025
Title: Shadi Mehraban: Innovator in Preterm Birth Prevention
Introduction
Shadi Mehraban is a notable inventor based in Salt Lake City, UT (US). He has made significant contributions to the field of maternal-fetal medicine, particularly in the prevention of preterm birth (PTB). His innovative work focuses on the development of effective treatments that can improve neonatal outcomes.
Latest Patents
Shadi Mehraban holds a patent for "Hydroxyprogesterone caproate compositions and methods of use in preventing preterm birth." This invention provides a dosing regimen that begins as early as 14 weeks of fetal gestation and can extend for up to 25 weeks. The composition delivers a high level of exogenous progestin to endogenous progesterone when it is most needed. The invention consistently achieves active levels of hydroxyprogesterone caproate (HPC) that are effective in preventing PTB. Exemplary dosing regimens include oral administration of HPC in the range of 1,200 mg to 1,600 mg, with options for once a day, twice a day, or three times a day administration.
Career Highlights
Throughout his career, Shadi Mehraban has focused on advancing medical treatments that address critical issues in obstetrics. His dedication to research and innovation has led to the development of effective therapies that can significantly impact maternal and neonatal health.
Collaborations
Shadi Mehraban has collaborated with esteemed colleagues, including Kilyoung Kim and Nachiappan Chidambaram. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.
Conclusion
Shadi Mehraban's work in the field of preterm birth prevention exemplifies the importance of innovation in healthcare. His patented compositions and methods represent a significant advancement in maternal-fetal medicine, offering hope for improved outcomes for mothers and their newborns.